Evaluation of Breastmilk Microbiota as a Function for Immunity
Comparison of Microbiota Composition and Antimicrobial Property From Breastmilk of Mothers With and Without Pregnancy Vaginal Infections
1 other identifier
observational
85
1 country
1
Brief Summary
The aim of this study is to evaluate the difference of breast milk microbiota between mothers with and without vaginal infections during pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2020
CompletedFirst Submitted
Initial submission to the registry
August 8, 2021
CompletedFirst Posted
Study publicly available on registry
August 13, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2021
CompletedMarch 18, 2022
March 1, 2022
12 months
August 8, 2021
March 17, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Breastmilk microbiota profiles
Differences in breastmilk microbiota profiles via pyrosequencing from breastmilk of women with or without history of vaginal infection during pregnancy
6 months
Secondary Outcomes (2)
Immuno-modulatory properties of breastmilk
6 months
Antimicrobial properties of breastmilk microbiota
6 months
Study Arms (2)
Group A
Lactating women with vaginal infection during pregnancy as confirmed by past medical records
Group B
Lactating women without any vaginal infection during pregnancy
Interventions
Eligibility Criteria
Subjects will be recruited from HUSM Kubang Kerian, USM Main Campus Penang, USM Kelantan and Institut Perubatan \& Pergigian Termaju USM.
You may qualify if:
- Lactating women
- Willing to commit throughout the experiment
You may not qualify if:
- Long term medication due to certain illnesses for over 3 months during pregnancy
- Gestational diabetes during pregnancy
- History of diabetes, coronary heart disease, and hypertension in life
- BMI before pregnancy above 24.9
- Consuming probiotic product during pregnancy
- Consuming probiotic product during lactation period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Main Campus USM
George Town, Pulau Pinang, 11800, Malaysia
Biospecimen
Human breastmilk samples will be collected in this study. The procedure of collecting sample is hands must be washed before milk expression, and nipples are cleaned with sterile water and alcohol swab. 15mL of fresh breast milk will be collected into a tube and stored at -20℃ until further analyses.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Min T Liong, PhD
Universiti Sains Malaysia
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 8, 2021
First Posted
August 13, 2021
Study Start
December 1, 2020
Primary Completion
November 30, 2021
Study Completion
November 30, 2021
Last Updated
March 18, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share